Thyroid Cancer Risk in Patients With Type 2 Diabetes Taking Glucagon‐Like Peptide 1 Receptor Agonists
T2DM patients taking GLP-1RA may not have an increased 5-year risk of TC compared to those taking metformin, SGLT-2I, or DPP-4I. Conclusions of long-term use are limited as most GLP-1RA were approved within the last decade.
Authors
- David Goldrich (ORCID: https://orcid.org/0000-0001-9132-0808)
- Bao Y. Sciscent (ORCID: https://orcid.org/0000-0002-3402-6335)
- Neerav Goyal (ORCID: https://orcid.org/0000-0001-6781-6467)
- David Goldenberg
- F. Jeffrey Lorenz
- Hanel W. Eberly
Institutions
- Penn State Milton S. Hershey Medical Center (US)
Publication Details
- Journal
- OTO Open
- Published
- 2026-01-01
- DOI
- https://doi.org/10.1002/oto2.70188
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00